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Abstract 
The objective of this study was to prepare diclofenac sodium loaded microparticles using the single 
emulsion [oil-in-water (o/w)] solvent evaporation method. The 2
2
 experimental design methodology was 
using the Design-Expert
®
 software used to evaluate the effect of two formulation variables on the 
properties of the microspheres in terms of particle size, morphology, encapsulation efficiency, and in vitro 
drug release. The graphical and mathematical analysis of the design showed that the independent 
variables had a significant effect on the encapsulation efficiency and drug release of microparticles. The 
low magnitudes of error and significant values of R
2
 prove the high prognostic ability of the design. The 
microspheres showed high encapsulation efficiency with an increase in the amount of polymer and a 
decrease in the amount of PVA in the formulation. The particles were found to be spherical with a smooth 
surface. Prolonged drug release and enhancement of encapsulation efficiency of polymeric microparticles 
can be successfully obtained by applying experimental design techniques. 
Keywords: Microencapsulation; Microparticles; Statistical experimental design; Solvent evaporation; 
Single emulsion; Drug delivery 
 
Introduction 
Biodegradable and biocompatible microparticles are popularly investigated drug delivery systems for 
therapeutic drugs [1-5]. They are capable of providing controlled release of the encapsulated drug over a 
long period of time [6,7]. Encapsulation of the drug within biomaterial-based microparticles can increase 
the stability of the drug and facilitate controlled and sustained release of the compound [8]. Recently, 
various different encapsulation techniques have been employed to produce fine particles of various active 
compounds. Many microencapsulation processes are modifications of the three basic techniques: solvent 
extraction/evaporation, phase separation (coacervation), and spray-drying techniques [9]. Solvent 
evaporation and organic phase separation techniques are widely used in the pharmaceutical industry for 
the preparation of microparticles [1,2,9-12]. These microparticles can reduce side effects, enhance 
the efficacy of therapy, and increase patient compliance. 
Non-steroidal anti-inflammatory drugs (NSAIDs) are usually indicated for the treatment of 
musculoskeletal disorders where pain and inflammation are present. Diclofenac sodium [sodium(o-((2,6-
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dichlorophenyl)-amino)-phenyl)-acetate] is a NSAID that is commonly used drug for the relief of pain and 
inflammation in arthritis, rheumatoid arthritis, osteoarthritis, and pain management in case of kidney 
stones. The dose is 100 to 150 mg daily with a short duration of action. Therefore, repeated dosing of the 
drug is essential for effective pain management. A major disadvantage of NSAID therapy is the potential for 
upper gastrointestinal (GI) complications and renal complications [13-19]. Due to the high usage of NSAIDs, 
a drug delivery formulation which will achieve the highest healing effect with minimal GI events is 
desirable. For that purpose, a sustained release formulation is essential. Therefore, polymeric 
microparticles of diclofenac sodium might be beneficial to overcome the side effects and increase efficacy 
of therapy and patient compliance. Diclofenac sodium and ethylcellulose were used as the model drug and 
polymer for the preparation of microparticles. Ethyl cellulose, an ethyl ether of cellulose, is a long chain 
polymer of β-anhydroglucose units joined together by acetal linkages. Ethylcellulose is a hydrophobic 
polymer widely used in the pharmaceutical field as a coating material for the preparation of microcapsules, 
microparticles, tablets, and for controlled release dosage forms due to its wide range of practically relevant 
properties, including low toxicity (FDA approved for internal use), good film forming abilities, and relatively 
low cost. High viscosity grades are used in drug microencapsulation and for sustained release products [13, 
20-23].  
Pharmaceutical scientists often using the single factor optimisation technique (one factor at a time) to 
optimise a formulation. Multiple factor optimisation is more efficient and generates a maximum point (an 
optimised condition) compared with the single factor optimisation technique. In many process 
development and manufacturing applications of pharmaceutical formulations, the number of potential 
input variables (factors) is greater. These formulations often face the challenge of identifying the key input 
variables or process conditions that affect product quality. However, this challenge can be overcome by 
using statistical design of experiment tools to carry out the minimum number of experiments to estimate 
the influence of individual variables on response variables [24-34]. 
The aim of this study was to evaluate, by means of a statistical experimental design methodology, the 
influence of the formulation variables on the encapsulation efficiency of diclofenac sodium loaded 




Diclofenac sodium was provided by Natco Pharma Limited, (Hyderabad, India) as a gift sample. 
Ethylcellulose was kindly donated by Colorcon India Pvt. Ltd. (Mumbai, India). Polyvinyl alcohol (PVA), (Mw 
140,000) was purchased from HiMedia Laboratories Pvt. Ltd. (Mumbai, India). Dichloromethane was 
obtained from Merck Specialities Pvt. Ltd. (Mumbai, India). Methanol (HPLC Grade) was purchased from 
RFCL Limited (New Delhi, India). All other solvents and reagents were of analytical grade and used as 
provided. 
Experimental design 
Before application of the design, a number of preliminary trials were conducted to determine the 
conditions at which the process resulted in microparticles. The levels of factors were also determined by 
this procedure. The 22 (two factors and two levels) factorial design was employed for the optimisation of 
diclofenac sodium loaded microparticles using the Design-Expert® Software (Version-8.0.7.1, Stat-Ease Inc., 
Minneapolis, MN) which allows evaluation from four experiments. The purpose of the design was to 
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evaluate the effects of the formulation factors and identify the key one that influences the encapsulation 
efficiency (Dependent variable). The amount of ethylcellulose (A, mg), and the amount of PVA (B, % w/v) 
were selected as independent variables. The levels of screening variables evaluated in this study are listed 
in Table 1 along with their low and high levels. Statistical analysis was performed and the significance of the 
model was determined by the comparisons of statistical parameters [35-37].  
 
Table 1. Screening variables and their levels (coded and actual) used for 2
2
 experimental design 
Independent variables Level used, actual (coded) 
 Low, (-1) High, (+1) 
A = Amount of ethylcellulose (mg) 250 750 
B = Amount of PVA as a surfactant (% w/v) 0.05 0.2 
 
Preparation of encapsulated microparticles 
Microparticles containing diclofenac sodium were prepared using the oil-in-water (O/W) single 
emulsion solvent evaporation method. Briefly, 250 mg of diclofenac sodium was mixed with a mixture of 
dichloromethane (10 ml), and methanol (10 ml) containing a certain proportion of ethylcellulose polymer as 
per the factorial design. This organic phase was dispersed in 100 ml of distilled water containing the varying 
amount of PVA as an emulsifier to produce an O/W single emulsion at a speed of 800 RPM using four 
bladed lab stirrers (Remi Electrotechnik Limited, Thane, India). The external aqueous phase was adjusted to 
pH 3.9 with acetic acid. Stirring was continued for 3 hours until the evaporation of organic solvent leaving 
solid microparticles. The microparticles were collected by filtration, rinsed with n-hexane, air dried for 48 
hours, and used for further studies.  
 
Characterisation of the microparticles 
The amount of diclofenac sodium encapsulated into microparticles was determined by UV-Vis 
spectrophotometer (HITACHI U-2900, Tokyo, Japan). An accurately weighed 10 mg of microparticles were 
stirred with dichloromethane (2 ml) to dissolve the polymeric coat, and was then extracted in phosphate 
buffer solution (pH 6.8). Stirring continued for 30 min at room temperature to facilitate the evaporation of 
organic solvent. The dispersion was filtered, and the residue was washed with phosphate buffer solution. 
The encapsulation efficiency was determined in the filtrate after appropriate dilution with a phosphate 
buffer solution at 276 nm using a UV-Vis spectrophotometer. The encapsulation efficiency was expressed as 
the percentage of drug incorporated in the formulation relative to the total amount of drug used in the 
formulation. The encapsulation efficiency of diclofenac sodium was calculated using the following equation: 
 
                           
[                          ]
[                    ]
                        
Of all the formulations, microparticles with a higher encapsulation efficiency were chosen for further 
characterisation study. 
The particle size and shape of the drug loaded microspheres was determined by capturing the series of 
digital images using Motic B1 advanced series digital microscope (Motic, China) fitted with imaging 
accessories equipped with computer-controlled image analysis software (Motic Images Plus, 2.0 ML 
Version). Calibration of an object lens was done using a standard calibrated circle. The sample was put on 
the slide, and the diameter of the particles was determined. 
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Drug release from microparticles was performed in vitro using phosphate buffer (pH 6.8) for 12 hours in 
a tablet dissolution tester (Electrolab TDT-06 T, India) USP XXVIII, type I (100 RPM, 37 ± 0.5°C). The 
dissolution medium of phosphate buffer (pH 6.8) was prepared according to the Indian Pharmacopoeia 
[38]. Aliquots of the dissolution medium were withdrawn at predetermined intervals and replenished with 
fresh dissolution media to maintain the sink condition. The samples were filtered through a Whatman filter 
paper no. 41. The diclofenac sodium content of each sample after suitable dilution was assayed by UV-Vis 
spectroscopy at λmax of 276 nm using a 1 cm cell. The experiments were done in triplicate. The release data 
were evaluated kinetically to study the possible mechanism of drug release from the microparticles. 
Results and Discussion 
Experimental design 
The statistical experimental design is a useful and efficient mathematical approach to evaluate the 
effect of a factor on a particular response generated by conducting a smaller number of experimental trials. 
Each analysed variable was evaluated at two levels, high (+1) and low (-1). The evaluation consisted of 
analysing the response in all the conditions quoted in Table 2. The polynomial model describing the 
correlation between the formulation process variables and encapsulation efficiency can be represented by 
the following equation: 
E.E. = 72.68 + 3.83A – 8.68B 
In the above equation a negative sign of variable B signifies the antagonistic effect, while a positive sign 
of variable A signifies a synergistic effect to the responses. It can be observed from the above equations 
that % E.E. was influenced by both factors. From the ANOVA of design for encapsulation efficiency, p-value, 
F-value, mean square and R2 of the model are given in Table 3. 
 
Table 2. The 2
2
 experimental design matrix (in coded level) and experimental results 
Run Independent variables Encapsulation Efficiency 
 A B  
1 750 0.05 84.93 ± 0.06 
2 750 0.2 68.08 ± 0.04 
3 250 0.2 59.91 ± 0.12 
4 250 0.05 77.78 ± 0.01 
 




d.f. Mean square F value 
p-Value 
Prob > F 
Model 359.87 2 179.94 691.51 0.0269 (S) 
   A- Ethylcellulose 58.68 1 58.68 225.50 0.0423 (S) 
   B- PVA 301.20 1 301.20 1157.52 0.0187 (S) 
Residual 0.26 1 0.26   
Total (Corrected) 360.13 3    
Correlation coefficient (R2) 0.9993     
Adjusted R2 0.9978     
Predicted R2 0.9884     
PRESS 4.16     
d.f.
 degree of freedom, 
S
 Significant 
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Standardised Pareto charts, (Fig. 1) representing the estimated effects of parameters on response, can 
allow us to check the statistical significance of experimental design. It consists of bars with a length 
proportional to the absolute value of the estimated effects divided by the standard error, which is the t-
value of the student’s t-test. It can be observed that ethylcellulose and PVA have significant influence on 
the encapsulation efficiency. 
 
Figure 1. Pareto chart of standardised effects on the encapsulation efficiency 
 
Characterisation of the microparticles 
The encapsulation efficiency of different experimental runs of microparticles is reported in Table 2. 
Two-dimensional (2D) contour plots and three-dimensional (3D) response plots resulting from the 
equations were constructed to visualise the effect of independent variables on the response using Design-
Expert® software [39]. It was observed that the encapsulation efficiency was higher with a high level of 
ethylcellulose and low level of PVA. Surface response plots and contour plots (Fig. 2 A & B) represent the 
increase in % encapsulation efficiency with an increase in the amount of ethylcellulose and a decrease in 
the amount of PVA. 
 
 
Figure 2. Response surface plot [A] and contour plot [B,] showing the effect of independent variables on response 
 
The shape, size, and surface morphology of the diclofenac sodium loaded microparticles were 
examined by Motic microscope. In this study, the particle size of the drug loaded microspheres captured 
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using Motic B1 advanced series digital microscope (Fig. 3) was found to be in the range of 10–200 µm. The 
particles were found to be discrete with spherical geometry.  
 
 
Figure 3. Image of microparticles by Motic microscope 
Ethylcellulose is a water insoluble polymer able to control drug release from microparticles. Fig. 4 
shows the cumulative % drug release as a function of the dissolution time from the diclofenac sodium 
loaded microparticles. The release of diclofenac sodium was evaluated using phosphate buffer (pH 6.8) as 
the release media. Prolonged drug release (92 %) (Fig. 4) from the microparticles was observed over 12 
hours. The dissolution data were fitted into the Matrix model equation. The sample showed good linearity 
(R2: 0.9764) with a value of the slope (n) < 0.45. It indicates that Fickian diffusion is the dominant 
mechanism of drug release from these microspheres. 
 




This work shows that diclofenac sodium loaded ethylcellulose polymeric microparticles were 
successfully prepared. The effects of formulation variables had been screened out by employing 22 
experimental design. The formulation variables have a significant effect on the encapsulation efficiency of 
microspheres. Design and optimisation through statistical experimental designs work well in the 
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development of polymeric microparticles. Microparticles prepared by such methods may represent a 
promising approach for the enhancement of encapsulation efficiency of diclofenac sodium. 
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